For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() The Allstate CorporationALL US · Financials · USD Current price$263.61as of Nov 19, 2026 Summary
Analyst consensusStrong Buy 2Buy 8Hold 11Sell 2Strong Sell 222 analysts 3-year price (USD)Factor profileMulti-factor score 94 / 100 Market data
Business descriptionThe Allstate Corporation (ALL) is a leading U.S. personal lines property-casualty insurer (based on earned premiums), writing mostly private passenger auto and homeowners insurance through exclusive agencies plus a multi-access model. Following divestitures of life/retirement units, ALL is now a focused P&C and protection franchise with $59.5B net written premiums in 2025. Competitive moatALL's moat is built on an exclusive agency network, brand ("Good Hands"), and a geographically diversified P&C book that is hard to replicate at scale. Underwriting discipline and pricing power — honed during the post-pandemic hard-market — drive superior combined ratios. The 2025 GAAP combined ratio improved to 85.2% (vs 94.3% in 2024), reflecting lower catastrophe claims and easing claims inflation. Recent developments
Investment risks / red flags
Financials
Classification
|
Theme Exposure
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: ALLBusiness description
The Allstate Corporation (ALL) is a leading U.S. personal lines property-casualty insurer (based on earned premiums), writing mostly private passenger auto and homeowners insurance through exclusive agencies plus a multi-access model. Following divestitures of life/retirement units, ALL is now a focused P&C and protection franchise with $59.5B net written premiums in 2025.
Competitive moat
ALL's moat is built on an exclusive agency network, brand ("Good Hands"), and a geographically diversified P&C book that is hard to replicate at scale. Underwriting discipline and pricing power — honed during the post-pandemic hard-market — drive superior combined ratios. The 2025 GAAP combined ratio improved to 85.2% (vs 94.3% in 2024), reflecting lower catastrophe claims and easing claims inflation.
Recent developments
- Q3 2026 (CFRA 11/17/2026): Adj. EPS USD 9.76 (vs USD 11.17) - beat CFRA USD 6.20 and consensus USD 6.96. Revenue USD 17,348M (+0.5%). Cat losses USD 1,650M (+7.1 pts) lifted recorded combined ratio to 86.6; underlying CR 80.5 (vs 78.7) as auto normalises (underlying auto CR 89.8 vs 86.0). Avg gross written premium -4.9% to USD 811 while PIF +3.4%; pure premium +2.7% after four declines.
- Homeowners: Earned premiums +11.5%, underlying CR stable 60.1; net rate +0.5% (uneven).
- Capital: Net investment income USD 1,177M (+USD 228M); ~USD 1.5B returned; shares 248.8M (-5.1% Y/Y). Employer Voluntary Benefits sale (USD 2B) completed - redeployment into core P&C.
- FY27 reset: CFRA models Oper. EPS falling to USD 28.20 in 2027 from 37.45 as pricing softens; Buy maintained on valuation (P/E ~7x).
- Q2 2026 beat: Adjusted EPS USD 8.99 vs USD 5.94 YoY and USD 6.07 consensus; total revenues USD 18,596M (+11.8% Y/Y). GAAP diluted EPS USD 12.51 (boosted by USD 1,055M net investment gains).
- Underwriting improved: P-L underwriting income USD 2,006M (+56.7% Y/Y); recorded combined ratio 86.6% (improved 4.5 pts Y/Y); underlying combined ratio 79.4% essentially flat Y/Y. Prior-year reserve releases contributed 4.6 pts.
- Auto discipline: Recorded auto combined ratio 83.3% (improved 2.7 pts Y/Y); underlying auto CR 87.6%. Policies in force +2.8% Y/Y; new-business apps +8.8% Y/Y across all distribution channels.
- Homeowners growth: Premiums written +8.1% Y/Y; underlying combined ratio 61.5% (deteriorated 2.9 pts Y/Y on higher loss costs).
- Investment income surge: Net investment income USD 1,009M (+33.8% Y/Y); total portfolio USD 87,802M (+13.4% Y/Y); equity securities USD 11,159M.
- Capital returns & balance sheet: Repurchased USD 1.0B in Q2 (USD 3.5B over trailing 12 months, ~6.7% of market cap). Shares out 253.5M (-3.9% Y/Y). Debt-to-capital improved to 18.2% (vs 25.2% YoY).
- Rating change (08/07/2026): CFRA lowered recommendation to BUY from STRONG BUY, reflecting valuation convergence while maintaining a bullish long-term thesis on P&C underwriting discipline.
- Portfolio streamlining: Completed historical divestitures (Employer Voluntary Benefits for $2B and Group Health for $1.25B in 2025; life insurance unit sale to Blackstone for $2.8B in 2021) to fully refocus capital on the core, high-return property-casualty franchise.
Investment risks / red flags
- Catastrophe exposure: Volatile weather patterns could drive above-expected weather/cat-related loss costs — the primary risk to rating and target.
- Auto rate competition: Greater-than-expected softening in auto rates + rising claim costs (tariff inflation risk) could compress margins.
- Product mix concentration: Lack of diversification beyond P&C flagged in risk assessment.
- Homeowners loss-cost trend: Underlying CR deterioration (61.5%, +2.9 pts Y/Y) worth monitoring.
Market Data
Source: mkts.io · Nov 19, 2026, 16:00 UTC
Key Metrics
Analyst Consensus
Calendar Events
Financials
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 9.66 | $17.68B |
| +1q | 8.34 | $17.74B |
| 0y | 38.90 | $70.29B |
| +1y | 28.51 | $72.74B |
Earnings
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Nov 10, 2026 | UBS | main | Neutral |
| Nov 10, 2026 | Morgan Stanley | main | Equal-Weight |
| Nov 10, 2026 | Keefe, Bruyette & Woods | main | Underperform |
| Nov 9, 2026 | Piper Sandler | main | Overweight |
| Nov 6, 2026 | Citigroup | main | Sell |
| Nov 6, 2026 | Wells Fargo | main | Equal-Weight |
